PERTH, Australia, March 17, 2026 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end Contract Development and Manufacturing Organisation (CDMO) announced it has initiated a comprehensive CMC ...
A reformulated RLS-2201 is being produced at BioCina’s sterile manufacturing facility in Perth, under conditions designed to confirm the reproducibility and robustness of the manufacturing process.
Beberapa hasil telah disembunyikan karena hasil tersebut mungkin tidak dapat Anda akses
Tampilkan hasil yang tidak dapat diakses